Neuropathic changes in the foot are common with
a prevalence of approximately 1%. The diagnosis of neuropathic arthropathy
is often delayed in diabetic patients with harmful consequences
including amputation. The appropriate diagnosis and treatment can
avoid an extensive programme of treatment with significant morbidity
for the patient, high costs and delayed surgery. The pathogenesis
of a Charcot foot involves repetitive micro-trauma in a foot with impaired
sensation and neurovascular changes caused by pathological innervation
of the blood vessels. In most cases, changes are due to a combination
of both pathophysiological factors. The Charcot foot is triggered
by a combination of mechanical, vascular and biological factors
which can lead to late diagnosis and incorrect treatment and eventually
to destruction of the foot. This review aims to raise awareness of the diagnosis of the Charcot
foot (diabetic
It is difficult to determine the safe timing
of weight-bearing or reconstructive surgery in patients with Charcot arthropathy
of the foot and ankle. In this study the Doppler spectrum of the
first dorsal metatarsal artery was used to monitor the activity
of the disease activity and served as a guideline for management.
A total of 15 patients (seven men and eight women) with acute diabetic
Charcot arthropathy of the foot and ankle were immobilised in a non-weight-bearing
cast. They were followed at two-week intervals and bilateral Doppler
spectra of the first dorsal metatarsal arteries were obtained using
a 10 MHz linear ultrasound probe. The patients were allowed to start weight-bearing
or undergo surgery after the Doppler spectrum had returned to normal
pattern. The Doppler spectra in the unaffected limbs were triphasic
in pattern, whereas those in limbs with active Charcot arthropathy
showed monophasic forward flow. They returned to normal after a
mean of 13.6 weeks (6 to 20) of immobilisation. Three patients underwent
pan-talar arthrodesis to correct gross instability and deformity. Doppler spectrum analysis of the foot may reflect the activity
of the disease in patients with Charcot arthropathy, and may be
used as a guide to begin weight-bearing or undergo reconstructive
surgery.
Charcot osteoarthropathy of the foot is a chronic and progressive disease of bone and joint associated with a risk of amputation. The main problems encountered in this process are osteopenia, fragmentation of the bones of the foot and ankle, joint subluxation or even dislocation, ulceration of the skin and the development of deep sepsis. We report our experience of a series of 20 patients with Charcot osteoarthropathy of the foot and ankle treated with an Ilizarov external fixator. The mean age of the group was 30 years (21 to 50). Diabetes mellitus was the underlying cause in 18 patients. Five had chronic ulcers involving the foot and ankle. Each patient had an open lengthening of the tendo Achillis with excision of all necrotic and loose bone from the ankle, subtalar and midtarsal joints when needed. The resulting defect was packed with corticocancellous bone graft harvested from the iliac crest and an Ilizarov external fixator was applied. Arthrodesis was achieved after a mean of 18 weeks (15 to 20), with healing of the skin ulcers. Pin track infection was not uncommon, but no frame had to be removed before the arthrodesis was sound. Every patient was able to resume wearing regular shoes after a mean of 26.5 weeks (20 to 45).
